These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 33206398)
1. LRRK2 at the pre-synaptic site: A 16-years perspective. Pischedda F; Piccoli G J Neurochem; 2021 Apr; 157(2):297-311. PubMed ID: 33206398 [TBL] [Abstract][Full Text] [Related]
2. Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2. Belluzzi E; Greggio E; Piccoli G Biochem Soc Trans; 2012 Oct; 40(5):1111-6. PubMed ID: 22988874 [TBL] [Abstract][Full Text] [Related]
3. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons. Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882 [TBL] [Abstract][Full Text] [Related]
4. LRRK2 along the Golgi and lysosome connection: a jamming situation. Piccoli G; Volta M Biochem Soc Trans; 2021 Nov; 49(5):2063-2072. PubMed ID: 34495322 [TBL] [Abstract][Full Text] [Related]
5. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease. Nguyen M; Krainc D Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704 [TBL] [Abstract][Full Text] [Related]
6. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila. Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024 [TBL] [Abstract][Full Text] [Related]
7. LRRK2 and membrane trafficking: nexus of Parkinson's disease. Hur EM; Jang EH; Jeong GR; Lee BD BMB Rep; 2019 Sep; 52(9):533-539. PubMed ID: 31383252 [TBL] [Abstract][Full Text] [Related]
12. The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions. Carrion MDP; Marsicano S; Daniele F; Marte A; Pischedda F; Di Cairano E; Piovesana E; von Zweydorf F; Kremmer E; Gloeckner CJ; Onofri F; Perego C; Piccoli G Sci Rep; 2017 Jul; 7(1):5377. PubMed ID: 28710481 [TBL] [Abstract][Full Text] [Related]
13. Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype. Rassu M; Biosa A; Galioto M; Fais M; Sini P; Greggio E; Piccoli G; Crosio C; Iaccarino C J Cell Mol Med; 2019 Dec; 23(12):8505-8510. PubMed ID: 31560168 [TBL] [Abstract][Full Text] [Related]
14. LRRK2 and the Endolysosomal System in Parkinson's Disease. Erb ML; Moore DJ J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192 [TBL] [Abstract][Full Text] [Related]
15. A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for Macroautophagy at Presynaptic Terminals. Soukup SF; Kuenen S; Vanhauwaert R; Manetsberger J; Hernández-Díaz S; Swerts J; Schoovaerts N; Vilain S; Gounko NV; Vints K; Geens A; De Strooper B; Verstreken P Neuron; 2016 Nov; 92(4):829-844. PubMed ID: 27720484 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein. Brzozowski CF; Hijaz BA; Singh V; Gcwensa NZ; Kelly K; Boyden ES; West AB; Sarkar D; Volpicelli-Daley LA Acta Neuropathol Commun; 2021 Nov; 9(1):180. PubMed ID: 34749824 [TBL] [Abstract][Full Text] [Related]
17. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. Piccoli G; Condliffe SB; Bauer M; Giesert F; Boldt K; De Astis S; Meixner A; Sarioglu H; Vogt-Weisenhorn DM; Wurst W; Gloeckner CJ; Matteoli M; Sala C; Ueffing M J Neurosci; 2011 Feb; 31(6):2225-37. PubMed ID: 21307259 [TBL] [Abstract][Full Text] [Related]
18. The role of LRRK2 in cytoskeletal dynamics. Civiero L; Cogo S; Biosa A; Greggio E Biochem Soc Trans; 2018 Dec; 46(6):1653-1663. PubMed ID: 30467120 [TBL] [Abstract][Full Text] [Related]
19. LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Matta S; Van Kolen K; da Cunha R; van den Bogaart G; Mandemakers W; Miskiewicz K; De Bock PJ; Morais VA; Vilain S; Haddad D; Delbroek L; Swerts J; Chávez-Gutiérrez L; Esposito G; Daneels G; Karran E; Holt M; Gevaert K; Moechars DW; De Strooper B; Verstreken P Neuron; 2012 Sep; 75(6):1008-21. PubMed ID: 22998870 [TBL] [Abstract][Full Text] [Related]
20. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease. Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]